VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Pulmonary Embolism
Interventions
DEVICE

VenaTech Convertible Vena Cava Filter

Prevention of Pulmonary Embolism

PROCEDURE

Vena Cava Filter Conversion

Conversion of VenaTech Convertible filter to open configuration.

Trial Locations (11)

10021

Weill Cornell Medical College - New York Presbyterian Hospital, New York

11030

North Shore University Hospital - Manhasset, Manhasset

15212

Allegheny General Hospital, Pittsburgh

19001

Abington Memorial Hospital, Abington

22908

University of Virginia Health Systems, Charlottesville

29403

Medical University of South Carolina, Charleston

33176

Baptist Hospital of Miami, Miami

48073

Beaumont Health System, Royal Oak

53226

Froedtert Memorial Lutheran Hospital, Milwaukee

60521

Adventist Health System, Hinsdale

60611

Northwestern Memorial Hospital, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bright Research Partners

INDUSTRY

collaborator

NAMSA

OTHER

lead

B. Braun Interventional Systems, Inc

INDUSTRY

NCT01112917 - VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial | Biotech Hunter | Biotech Hunter